As global markets react to a "red sweep" in the U.S., small-cap stocks have shown notable activity, with the Russell 2000 Index leading gains but still trailing its previous record highs. This dynamic ...
The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...
Expansion in Emerging Markets: The growing prevalence of hearing loss in developing regions and rising healthcare accessibility present untapped opportunities for market players. Investments in ...